Results 141 to 150 of about 34,150 (257)

Incidental Resolution of Dopamine Agonist Induced Impulse Control Disorder with GLP‐1 Receptor Agonist

Movement Disorders Clinical Practice, EarlyView.
Hannah Kelly, Thomas Davis
wiley   +1 more source

Advancing Quantitative Susceptibility Mapping With 2.5D Diffusion Models for Rapid Intracranial Hemorrhage Quantification

Magnetic Resonance in Medicine, EarlyView.
ABSTRACT Purpose To develop a generative diffusion model‐based approach for robust and efficient quantitative susceptibility mapping (QSM) reconstruction in intracranial hemorrhage (ICH), applicable to both standard gradient echo (GRE) and rapid echo planar imaging (EPI) acquisitions.
Zhuang Xiong, Yang Gao, Feng Liu, Derek Emery, Ken Butcher, Alan H. Wilman, Hongfu Sun   +6 more
wiley   +1 more source

Modelling phenomenological differences in aetiologically distinct visual hallucinations using deep neural networks. [PDF]

Front Hum Neurosci, 2023
Suzuki K, Seth AK, Schwartzman DJ.
europepmc   +1 more source

Improving Advance Care Planning for People with Parkinson's

Movement Disorders Clinical Practice, EarlyView.
Bradley Lonergan, Peter Miller, Elisabete Marques, Yen Tai, Anette Schrag   +4 more
wiley   +1 more source

VQ‐Wave: A Physics‐Driven Spatiotemporal Deep Learning Approach for Noncontrast‐Enhanced Lung Ventilation and Perfusion MRI

Magnetic Resonance in Medicine, EarlyView.
ABSTRACT Purpose To develop a robust deep learning framework for noncontrast‐enhanced functional lung MRI, overcoming the limitations of spectral decomposition in the presence of physiological nonstationarity. Methods We introduce VQ‐Wave (Ventilation/Q‐perfusion Waveform‐based Assessment of Variable Evolutions), a physics‐driven spatiotemporal ...
Grzegorz Bauman, Pavlos Panos, Philipp Latzin, Oliver Bieri   +3 more
wiley   +1 more source

Stroboscopically induced visual hallucinations: historical, phenomenological, and neurobiological perspectives. [PDF]

Neurosci Conscious
Hewitt T, Amaya I, Beauté R, Seth AK, Schmidt TT, Schwartzman DJ.   +5 more
europepmc   +1 more source

Neuroprotective effects of ursodeoxycholic acid in Parkinson's disease and Alzheimer's disease

Neuroprotection, EarlyView.
In Parkinson's disease (PD) and Alzheimer's disease (AD), various shared pathological mechanisms exist. UDCA has been shown to exert neuroprotective effects in preclinical and clinical studies. Such effects include the mitigation of neuroinflammation as well as rescue effects on mitochondrial dysfunction, oxidative stress, impaired autophagy, and ...
Ashley En Yi Chong, Andrew Octavian Sasmita, Rhun Yian Koh, Anna Pick Kiong Ling   +3 more
wiley   +1 more source

Imaging patterns and genetic associations of brain atrophy across distinct symptom stages in Parkinson's disease

Neuroprotection, EarlyView.
Early disease stages showed limited cortical atrophy and enrichment of synaptic and calcium signaling pathways, whereas advanced stages demonstrated widespread cortical degeneration associated with immune activation and extracellular matrix remodeling.
Yi Ji, Liujia Lu, Kaidong Chen, Ruixuan Zhang, Yao Lu, Yachen Shi, Xiangming Fang   +6 more
wiley   +1 more source

Combined Dysfunction of the Amygdala and Nucleus Basalis Underlies Visual Hallucinations in Parkinson's Disease. [PDF]

Mov Disord
Ignatavicius A, Churchill L, Anderson J, Konuri A, O'Callaghan C, Lewis SJG, Matar E.   +6 more
europepmc   +1 more source

Pulvinar quantitative susceptibility mapping predicts visual hallucinations post-deep brain stimulation in Parkinson's disease. [PDF]

Brain Behav, 2023
Matsuura K, Ii Y, Maeda M, Tabei KI, Satoh M, Umino M, Kajikawa H, Araki T, Nakamura N, Matsuyama H, Shindo A, Tomimoto H.   +11 more
europepmc   +1 more source